메뉴 건너뛰기




Volumn 8, Issue 4, 2014, Pages 603-610

Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors

Author keywords

Breast cancer; Endocrine therapy; Medicaid; Survivorship

Indexed keywords

BREAST NEOPLASMS; FEMALE; HUMAN; MEDICAID; MIDDLE AGED; MORTALITY; SURVIVOR; UNITED STATES;

EID: 84936765943     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-014-0365-3     Document Type: Article
Times cited : (31)

References (32)
  • 2
    • 71949086203 scopus 로고    scopus 로고
    • Caring for patients with cancer histories in community-based primary care settings: a survey of primary care physicians in the southeastern US
    • Burg MA, Grant K, Hatch R. Caring for patients with cancer histories in community-based primary care settings: a survey of primary care physicians in the southeastern US. Prim Health Care Res Dev. 2005;6(03):244–50. doi:10.1191/1463423605pc250oa.
    • (2005) Prim Health Care Res Dev , vol.6 , Issue.3 , pp. 244-250
    • Burg, M.A.1    Grant, K.2    Hatch, R.3
  • 3
    • 78650339362 scopus 로고    scopus 로고
    • Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study
    • PID: 21169259
    • O’Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16(24):6100–10. doi:10.1158/1078-0432.CCR-10-1533.
    • (2010) Clin Cancer Res , vol.16 , Issue.24 , pp. 6100-6110
    • O’Brien, K.M.1    Cole, S.R.2    Tse, C.K.3    Perou, C.M.4    Carey, L.A.5    Foulkes, W.D.6
  • 4
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
    • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717. doi:10.1016/S0140-6736(05)66544-0
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
  • 5
    • 79959325702 scopus 로고    scopus 로고
    • Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer
    • PID: 21606426
    • Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18):2534–42. doi:10.1200/JCO.2010.33.3179.
    • (2011) J Clin Oncol , vol.29 , Issue.18 , pp. 2534-2542
    • Neugut, A.I.1    Subar, M.2    Wilde, E.T.3    Stratton, S.4    Brouse, C.H.5    Hillyer, G.C.6
  • 6
    • 77957936884 scopus 로고    scopus 로고
    • Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients
    • PID: 20585090
    • Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120–8. doi:10.1200/JCO.2009.25.9655.
    • (2010) J Clin Oncol , vol.28 , Issue.27 , pp. 4120-4128
    • Hershman, D.L.1    Kushi, L.H.2    Shao, T.3    Buono, D.4    Kershenbaum, A.5    Tsai, W.Y.6
  • 7
    • 56749152357 scopus 로고    scopus 로고
    • Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
    • COI: 1:CAS:528:DC%2BD1cXhsVajtbrL, PID: 18985046
    • McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer. 2008;99(11):1763–8. doi:10.1038/sj.bjc.6604758.
    • (2008) Br J Cancer , vol.99 , Issue.11 , pp. 1763-1768
    • McCowan, C.1    Shearer, J.2    Donnan, P.T.3    Dewar, J.A.4    Crilly, M.5    Thompson, A.M.6
  • 8
    • 79956104201 scopus 로고    scopus 로고
    • Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
    • COI: 1:CAS:528:DC%2BC3MXjtFSrtrw%3D, PID: 20803066
    • Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529–37. doi:10.1007/s10549-010-1132-4.
    • (2011) Breast Cancer Res Treat , vol.126 , Issue.2 , pp. 529-537
    • Hershman, D.L.1    Shao, T.2    Kushi, L.H.3    Buono, D.4    Tsai, W.Y.5    Fehrenbacher, L.6
  • 9
    • 73749086933 scopus 로고    scopus 로고
    • Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
    • PID: 19299162
    • Hadji P. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy. Crit Rev Oncol Hematol. 2010;73(2):156–66. doi:10.1016/j.critrevonc.2009.02.001.
    • (2010) Crit Rev Oncol Hematol , vol.73 , Issue.2 , pp. 156-166
    • Hadji, P.1
  • 10
    • 0035863386 scopus 로고    scopus 로고
    • Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women
    • COI: 1:CAS:528:DC%2BD3MXhtVektrk%3D, PID: 11208822
    • Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol. 2001;19(2):322–8.
    • (2001) J Clin Oncol , vol.19 , Issue.2 , pp. 322-328
    • Demissie, S.1    Silliman, R.A.2    Lash, T.L.3
  • 11
    • 70249110823 scopus 로고    scopus 로고
    • Adjuvant hormonal therapy use among insured, low-income women with breast cancer
    • PID: 19451445
    • Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol. 2009;27(21):3445–51. doi:10.1200/JCO.2008.19.2419.
    • (2009) J Clin Oncol , vol.27 , Issue.21 , pp. 3445-3451
    • Kimmick, G.1    Anderson, R.2    Camacho, F.3    Bhosle, M.4    Hwang, W.5    Balkrishnan, R.6
  • 12
    • 84864452219 scopus 로고    scopus 로고
    • Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer
    • PID: 22773822
    • Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, et al. Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012;104(14):1102–5. doi:10.1093/jnci/djs273.
    • (2012) J Natl Cancer Inst , vol.104 , Issue.14 , pp. 1102-1105
    • Yung, R.L.1    Hassett, M.J.2    Chen, K.3    Gesten, F.C.4    Roohan, P.J.5    Boscoe, F.P.6
  • 13
    • 84856230195 scopus 로고    scopus 로고
    • Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
    • PID: 21922245
    • Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, et al. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2011;131(2):607–17. doi:10.1007/s10549-011-1762-1.
    • (2011) Breast Cancer Res Treat , vol.131 , Issue.2 , pp. 607-617
    • Livaudais, J.C.1    Hershman, D.L.2    Habel, L.3    Kushi, L.4    Gomez, S.L.5    Li, C.I.6
  • 14
    • 77951123003 scopus 로고    scopus 로고
    • Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view
    • PID: 19507263
    • Pellegrini I, Sarradon-Eck A, Soussan PB, Lacour AC, Largillier R, Tallet A, et al. Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view. Psychooncology. 2010;19(5):472–9. doi:10.1002/pon.1593.
    • (2010) Psychooncology , vol.19 , Issue.5 , pp. 472-479
    • Pellegrini, I.1    Sarradon-Eck, A.2    Soussan, P.B.3    Lacour, A.C.4    Largillier, R.5    Tallet, A.6
  • 15
    • 79958709842 scopus 로고    scopus 로고
    • Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
    • COI: 1:CAS:528:DC%2BC3MXjtFSrtrc%3D, PID: 21249443
    • Dent SF, Gaspo R, Kissner M, Pritchard KI. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat. 2011;126(2):295–310. doi:10.1007/s10549-011-1351-3.
    • (2011) Breast Cancer Res Treat , vol.126 , Issue.2 , pp. 295-310
    • Dent, S.F.1    Gaspo, R.2    Kissner, M.3    Pritchard, K.I.4
  • 16
    • 39149111976 scopus 로고    scopus 로고
    • Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
    • COI: 1:CAS:528:DC%2BD1cXis1alsrc%3D, PID: 18180462
    • Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26(4):556–62. doi:10.1200/jco.2007.11.5451.
    • (2008) J Clin Oncol , vol.26 , Issue.4 , pp. 556-562
    • Partridge, A.H.1    LaFountain, A.2    Mayer, E.3    Taylor, B.S.4    Winer, E.5    Asnis-Alibozek, A.6
  • 17
    • 0037441639 scopus 로고    scopus 로고
    • Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    • COI: 1:CAS:528:DC%2BD2cXpsVGrtbs%3D, PID: 12586795
    • Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21(4):602–6.
    • (2003) J Clin Oncol , vol.21 , Issue.4 , pp. 602-606
    • Partridge, A.H.1    Wang, P.S.2    Winer, E.P.3    Avorn, J.4
  • 18
    • 84879073660 scopus 로고    scopus 로고
    • Is medical home enrollment associated with receipt of guideline-concordant follow-up care among low-income breast cancer survivors?
    • PID: 23673393
    • Wheeler SB, Kohler RE, Goyal RK, Lich KH, Lin C-C, Moore A, et al. Is medical home enrollment associated with receipt of guideline-concordant follow-up care among low-income breast cancer survivors? Med Care. 2013;51(6):494–502. doi:10.1097/MLR.0b013e31828d4d0c.
    • (2013) Med Care , vol.51 , Issue.6 , pp. 494-502
    • Wheeler, S.B.1    Kohler, R.E.2    Goyal, R.K.3    Lich, K.H.4    Lin, C.-C.5    Moore, A.6
  • 19
    • 33750935710 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting
    • PID: 17033037
    • Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7. doi:10.1200/JCO.2006.08.8575.
    • (2006) J Clin Oncol , vol.24 , Issue.31 , pp. 5091-5097
    • Khatcheressian, J.L.1    Wolff, A.C.2    Smith, T.J.3    Grunfeld, E.4    Muss, H.B.5    Vogel, V.G.6
  • 20
    • 81755181772 scopus 로고    scopus 로고
    • Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
    • COI: 1:STN:280:DC%2BC38zltVWhsg%3D%3D, PID: 21788360
    • Cluze C, Rey D, Huiart L, BenDiane MK, Bouhnik AD, Berenger C, et al. Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Ann Oncol. 2012;23(4):882–90. doi:10.1093/annonc/mdr330.
    • (2012) Ann Oncol , vol.23 , Issue.4 , pp. 882-890
    • Cluze, C.1    Rey, D.2    Huiart, L.3    BenDiane, M.K.4    Bouhnik, A.D.5    Berenger, C.6
  • 21
    • 33748522756 scopus 로고    scopus 로고
    • Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective
    • COI: 1:CAS:528:DC%2BD28Xps1Cltb0%3D, PID: 16978958
    • Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N. Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg. 2006;192(4):496–8. doi:10.1016/j.amjsurg.2006.06.018.
    • (2006) Am J Surg , vol.192 , Issue.4 , pp. 496-498
    • Garreau, J.R.1    Delamelena, T.2    Walts, D.3    Karamlou, K.4    Johnson, N.5
  • 22
    • 34247354217 scopus 로고    scopus 로고
    • Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use
    • PID: 17446829
    • Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care. 2007;45(5):431–9. doi:10.1097/01.mlr.0000257193.10760.7f.
    • (2007) Med Care , vol.45 , Issue.5 , pp. 431-439
    • Kahn, K.L.1    Schneider, E.C.2    Malin, J.L.3    Adams, J.L.4    Epstein, A.M.5
  • 23
    • 40349097819 scopus 로고    scopus 로고
    • Treatment variation by insurance status for breast cancer patients
    • PID: 18315690
    • Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J. 2008;14(2):128–34. doi:10.1111/j.1524-4741.2007.00542.x.
    • (2008) Breast J , vol.14 , Issue.2 , pp. 128-134
    • Coburn, N.1    Fulton, J.2    Pearlman, D.N.3    Law, C.4    DiPaolo, B.5    Cady, B.6
  • 24
    • 41749092567 scopus 로고    scopus 로고
    • Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005)
    • PID: 18364506
    • Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.
    • (2008) J Natl Cancer Inst , vol.100 , Issue.7 , pp. 462-474
    • Chen, A.Y.1    Halpern, M.T.2    Schrag, N.M.3    Stewart, A.4    Leitch, M.5    Ward, E.6
  • 25
    • 32444442071 scopus 로고    scopus 로고
    • The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida
    • PID: 16244785
    • Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat. 2006;95(1):89–95.
    • (2006) Breast Cancer Res Treat , vol.95 , Issue.1 , pp. 89-95
    • Voti, L.1    Richardson, L.C.2    Reis, I.3    Fleming, L.E.4    Mackinnon, J.5    Coebergh, J.W.6
  • 26
    • 34447285278 scopus 로고    scopus 로고
    • Lost opportunities: physicians’ reasons and disparities in breast cancer treatment
    • PID: 17577028
    • Bickell NA, LePar F, Wang JJ, Leventhal H. Lost opportunities: physicians’ reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25(18):2516–21.
    • (2007) J Clin Oncol , vol.25 , Issue.18 , pp. 2516-2521
    • Bickell, N.A.1    LePar, F.2    Wang, J.J.3    Leventhal, H.4
  • 27
    • 80053654178 scopus 로고    scopus 로고
    • Caring for survivors of breast cancer: perspective of the primary care physician
    • COI: 1:STN:280:DC%2BC3MfptlOhsA%3D%3D, PID: 21980253
    • Smith SL, Wai ES, Alexander C, Singh-Carlson S. Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol. 2011;18(5):e218–26.
    • (2011) Curr Oncol , vol.18 , Issue.5 , pp. e218-e226
    • Smith, S.L.1    Wai, E.S.2    Alexander, C.3    Singh-Carlson, S.4
  • 28
    • 71549137422 scopus 로고    scopus 로고
    • Survivorship: adult cancer survivors
    • PID: 19913184
    • Ganz PA. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41. doi:10.1016/j.pop.2009.08.001.
    • (2009) Prim Care , vol.36 , Issue.4 , pp. 721-741
    • Ganz, P.A.1
  • 29
    • 83655201442 scopus 로고    scopus 로고
    • Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors
    • PID: 21785923
    • Potosky A, Han PJ, Rowland J, Klabunde C, Smith T, Aziz N, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26(12):1403–10. doi:10.1007/s11606-011-1808-4.
    • (2011) J Gen Intern Med , vol.26 , Issue.12 , pp. 1403-1410
    • Potosky, A.1    Han, P.J.2    Rowland, J.3    Klabunde, C.4    Smith, T.5    Aziz, N.6
  • 30
    • 84855361967 scopus 로고    scopus 로고
    • Do Survivorship care plans make a difference? A primary care provider perspective
    • PID: 22211129
    • Shalom MM, Hahn EE, Casillas J, Ganz PA. Do Survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract. 2011;7(5):314–8. doi:10.1200/JOP.2010.000208.
    • (2011) J Oncol Pract , vol.7 , Issue.5 , pp. 314-318
    • Shalom, M.M.1    Hahn, E.E.2    Casillas, J.3    Ganz, P.A.4
  • 31
    • 0037012339 scopus 로고    scopus 로고
    • Race, socioeconomic status, and breast cancer treatment and survival
    • PID: 11929949
    • Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6. doi:10.1093/jnci/94.7.490.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.7 , pp. 490-496
    • Bradley, C.J.1    Given, C.W.2    Roberts, C.3
  • 32
    • 0036841321 scopus 로고    scopus 로고
    • Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies
    • PID: 12404294
    • Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002;95(9):1988–99.
    • (2002) Cancer , vol.95 , Issue.9 , pp. 1988-1999
    • Cross, C.K.1    Harris, J.2    Recht, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.